Simplify Logo

Full-Time

Technician

Upstream Process Development, CMC

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

$53.9k - $67.3kAnnually

+ Equity + Annual Bonus

Entry, Junior

Vancouver, BC, Canada

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • You have a degree or diploma in Biotechnology, Biochemistry, Chemical Engineering, or a related field
  • You have experience of monitoring and maintaining mammalian cell cultures including good aseptic technique
  • You have demonstrated strong technical skills and a keen eye for detail
  • You are excited to learn about setting up and running bioreactor systems
  • You enjoy working collaboratively in a fast-paced and dynamic team environment
  • You have a passion for excellent documentation and organizational skills, with the ability to maintain detailed and accurate records
  • You are comfortable with basic laboratory techniques and equipment maintenance
  • You have strong problem-solving skills and a proactive approach to troubleshooting
  • You are committed to maintaining a safe and compliant laboratory environment
Responsibilities
  • Setting up and operating 2L and 10L bioreactors, ensuring optimal conditions for cell culture processes
  • Supporting the setup and execution of ambr15 and ambr250 automated high-throughput mini-bioreactor systems
  • Monitoring and maintaining bioreactor conditions, including pH, temperature, dissolved oxygen, and agitation rates
  • Performing routine sampling and analysis of cell culture parameters to ensure consistency and quality
  • Collaborating with senior scientists and engineers to troubleshoot and optimize bioprocesses
  • Maintaining accurate and detailed records of experimental procedures, results, and observations using Benchling
  • Preparing media, buffers, and other solutions required for cell culture experiments
  • Performing equipment calibration, maintenance, and troubleshooting to ensure reliable operation
  • Participating in process development meetings and contributing to discussions on process improvements
  • Ensuring compliance with all safety and quality standards in the laboratory environment

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

4%

1 year growth

1%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.